Carpal Tunnel Corticosteroid Injection Treatment of Nail Lichen Planus
Main Article Content
Keywords
Nail lichen planus, corticosteroid, treatments, inflammatory nail disorders
Abstract
Treatment for nail lichen planus (NLP) typically involves the use of intralesional or systemic corticosteroids. However, both modalities have distinct considerations. Systemic options are typically reserved for severe cases due to potential adverse effects while intralesional injections are limited due to patient discomfort. Here we present a case in which a corticosteroid injection for carpal tunnel syndrome led to incidental bilateral improvement in a patient’s nail lichen planus. Carpal tunnel injection may be an alternative to more traditional treatments and is a potential area for further research.
References
2. Reddy S, Ananthakrishnan S, Garg A. A prospective observational study evaluating hypothalamic-pituitary-adrenal axis alteration and efficacy of intramuscular triamcinolone acetonide for steroid-responsive dermatologic disease. J Am Acad Dermatol. 2013;69(2). doi:10.1016/j.jaad.2013.02.005
3. Clark A, Jellinek NJ. Intralesional injection for inflammatory nail diseases. Dermatologic Surgery. 2016;42(2). doi:10.1097/DSS.0000000000000621
4. Piraccini BM, Saccani E, Starace M, Balestri R, Tosti A. Nail lichen planus: Response to treatment and long term follow-up. European Journal of Dermatology. 2010;20(4). doi:10.1684/ejd.2010.0952
5. Jiménez del Barrio S, Bueno Gracia E, Hidalgo García C, et al. Conservative treatment in patients with mild to moderate carpal tunnel syndrome: A systematic review. Neurologia. 2018;33(9). doi:10.1016/j.nrl.2016.05.018
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.